Kiora PharmaceuticalsKPRX
13F holders, Q1 2026 (March 31)18holders −1
4new positions
7sold out
1famous investor
$1.93avg. 13F price*
At the end of Q1 2026, 18 institutions reported holding Kiora Pharmaceuticals Inc. (KPRX) in their 13F filings, down 1 from Q4 2025. 4 opened new positions and 7 sold out. The largest holders were ADAR1 Capital Management, LLC ($324K), Citadel Advisors ($96K) and Geode Capital Management, LLC ($92K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Kiora Pharmaceuticals Inc.
- CUSIP
- 49721T507
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $45K |
| Exits | 7 | $880K |
All 13F filers, Q4 2025 → Q1 2026: 79,562 shares bought and 447,304 shares sold, net −367,742 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| ADAR1 Capital Management, LLC | 0.02% | No change | 167,941 | $324K |
| Citadel Advisors | 0.00% | Add +121.3% | 49,533 | $96K |
| Geode Capital Management, LLC | 0.00% | Add +117.4% | 47,850 | $92K |
| Vanguard Capital Management LLC | 0.00% | — | 19,861 | $38K |
| XTX Topco Ltd | 0.00% | Add +23.0% | 14,719 | $28K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 13,030 | $25K |
| Two Sigma Securities, LLC | 0.00% | New | 12,019 | $23K |
| Rangeley Capital, LLC | 0.02% | New | 10,000 | $19K |
| Morgan Stanley | 0.00% | New | 1,408 | $3K |
| UBS Group AG | 0.00% | Add +42.6% | 1,301 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -37.2% | 995 | $2K |
| SBI Securities Co., Ltd. | 0.00% | No change | 256 | $494 |
| Vanguard Global Advisers, LLC | 0.00% | — | 200 | $386 |
| BlackRock, Inc. | 0.00% | No change | 58 | $112 |
| NewEdge Advisors, LLC | 0.00% | No change | 22 | $42 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 6 | $12 |
| Activest Wealth Management | 0.00% | No change | 2 | $4 |
| Osaic Holdings, Inc. | 0.00% | No change | 2 | $3 |
"% of holder's portfolio" is KPRX's weight in each manager's 13F, not the share of Kiora Pharmaceuticals Inc. the manager owns.